Sequoia Capital Israel

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Wuxi Gongwang inductive sensor developer offering high-precision, oil and dust-resistant products for various industries, including aerospace, automotive, medical care, and more.

Taiyi Guanjia is a company that combines technology and medical health innovation, aiming to enhance the insurance industry and create a robust medical and health ecosystem.

Full-Life Technologies specializes in developing and commercializing radiopharmaceuticals for cancer therapy. It offers research and development, production, and distribution services within the radiotherapy sector, aiming to enhance patient outcomes through innovative nuclear medicine solutions.

Spear Bio is a biotechnology company based in Weston, Massachusetts, founded in 2021. The company specializes in ultrasensitive protein detection technology, which significantly enhances healthcare diagnostics. Its innovative approach enables the quantification of minute protein biomarkers from samples collected at home, facilitating self-testing and telemedicine applications. By allowing clinicians to detect these biomarkers from small sample volumes, Spear Bio's technology integrates seamlessly into existing workflows for sample collection, processing, and detection, thereby improving the overall efficiency of healthcare delivery.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Noah Medical is a manufacturer of medical robotic devices specialized in the diagnosis and treatment of patients across various medical conditions. The company's innovative devices facilitate early diagnoses and treatments within advanced clinical environments, empowering hospitals to address health issues promptly. This capability not only enhances patient outcomes but also contributes to reduced scarring, thereby improving the overall quality of care.

Huayuan Regenerative Medicine is the manufacture of implantable bioartificial organs. Huayuan Regenerative Medicine is committed to the research and development, production, and sales of clinical grade stem cells, biological tissue engineering products, and biomanufacturing. Their clinical products include urinary kidney precursor cells, dialysis equipment, and a biosynthetic artificial pancreas.

Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.

Founded in 2012, Vivolight is a medical device company incubated and supported by Xi'an Institute of Optics and Precision Mechanics of Chinese Academy of Sciences. We are headquartered in Shenzhen and have established an R&D center in Xi’an. Rooted in the field of medical laser technology, we are committed to the independent development, global innovation and independent manufacturing of medical devices used for minimally invasive interventional diagnosis and treatment with the technology of laser by leveraging the world-leading photoelectric technology and combining medicine and engineering. In April 2020, our self-developed optical coherence tomography (OCT) system obtained the approval of NMPA and achieved commercialization. In December 2021, our innovative Multimodality OCT System was approved by NMPA. It is the first Multimodality OCT System in the field of coronary artery OCT that has been approved for clinical application. In the field of interventional laser therapy, we have multiple products that have entered the phase of pre-clinical study.

EagleChip is a chip design company specializing in the development and design of Field Programmable Gate Arrays (FPGAs). The company emphasizes research and development as well as the creation of dedicated Electronic Design Automation (EDA) toolchains. Its products are applicable across various industries, including communications, data centers, industrial control, consumer electronics, smart vehicles, video processing, and medical electronics. By providing high-quality FPGA chip solutions, EagleChip aims to meet the diverse needs of its customers while ensuring a domestic supply of advanced technology.

Spectrum Medical is a clinical mass spectrometry product platform that promotes clinical mass spectrometry detection technology to the general public. It has an experienced research and development, operations, and sales team, a standardized GMP production workshop, extensive experience in laboratory construction, and a mature laboratory management system. It provides with complete supporting kits in addition to mastering the core mass spectrometry hardware manufacturing technology and equipment integration development capabilities (maternal and child genetics, nutritional levels, therapeutic drug testing, metabolic monitoring, etc.).

NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

Full-Life Technologies specializes in developing and commercializing radiopharmaceuticals for cancer therapy. It offers research and development, production, and distribution services within the radiotherapy sector, aiming to enhance patient outcomes through innovative nuclear medicine solutions.

Scientech Medical engages in the research, development, and manufacturing of interventional medical devices.

SceneRay Co. Ltd, based in Singapore Industrial Park in Suzhou, China, is a medical device company specializing in the design, development, and distribution of neuromodulation devices. The company focuses on creating advanced medical products, including a dual-channel implantable pulse generator kit for deep brain stimulation. This technology is designed to provide effective treatments for patients suffering from brain damage through electric stimulation. SceneRay's core team comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, both in China and internationally. The company holds numerous patents and is committed to exploring innovative solutions in the field of neuromodulation, aiming to deliver high-quality and effective treatments to improve patient outcomes.

Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic (IVD) company based in Suzhou, China, with a research and development office in Singapore. Founded in 2019, the company specializes in developing advanced diagnostic platforms for the detection of infectious diseases, cancer, and chronic diseases. Its technology offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Virtue Diagnostics aims to enhance diagnostic capabilities and improve patient outcomes through its innovative solutions.

Vico Medical, established in 2018 and based in Wuhan, China, specializes in the development and production of medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including atrial shunts, puncture systems, and occluders for patent foramen ovale, along with delivery systems and other related devices. Vico Medical focuses on providing innovative intervention treatment solutions for structural cardiovascular issues, contributing to the reduction of stroke and heart-related disease incidents.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

SyMap Medical is focused on the development and manufacturing of innovative medical devices aimed at treating hypertension and related diseases, including heart failure, arrhythmia, and severe asthma. The company specializes in a proprietary catheter-based renal mapping and ablation system that utilizes radiofrequency (RF) ablation technology. This system is designed for renal denervation therapy, which involves mapping and selectively ablating renal nerves to effectively manage hypertension. Through its advanced technology platform, SyMap Medical aims to address significant health challenges associated with major cardiovascular and respiratory conditions.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company focuses on creating a comprehensive range of biological heart valves and annuloplasty rings that are designed to be minimally invasive. Utilizing cutting-edge technologies, including anti-calcification and leaflet thinning methods, KingstronBio aims to provide innovative solutions that enhance patient outcomes and improve the overall effectiveness of cardiac procedures.

Edge Medical Robotics, Inc. is a Shenzhen, China-based company that specializes in the design and development of advanced surgical equipment. Founded on May 4, 2017, the company is dedicated to researching and promoting cutting-edge smart technologies aimed at enhancing surgical safety and treatment efficacy. By focusing on the pursuit of excellence and refinement in its products, Edge Medical Robotics seeks to elevate health standards and improve overall social health outcomes.

magAssist, founded in 2017 by Dr. Xu Bozhen, is a high-tech enterprise based in Suzhou, specializing in the development of in-vitro artificial heart devices aimed at assisting patients with cardiovascular diseases. The company focuses on creating short-term to medium-term ventricular assist devices that are compatible with various blood types. Utilizing advanced fluid mechanics and magnetic suspension technology, magAssist aims to minimize incompatibility issues in patients, thereby enhancing their recovery and treatment processes. The core team consists of leading experts in artificial heart engineering, leveraging extensive experience in research and development to produce domestically manufactured devices with independent intellectual property rights.

Vision X is a solutions provider for medical equipment in the field of ophthalmology and optometry.

Geneus develops and commercializes gene sequencers and reagents. The core of its technology is based on the characteristic current signal generated by the interaction of protein nanopores and nucleic acid bases, and it realizes single-molecule nucleic acid sequencing through an integrated chip system.

Eighteeth focuses on the research and production of dental instruments. Eighteeth has 14 product categories including endo motor, apex locator, ultrasonic scaler, curing light, X-Ray unit, intraoral sensor, intraoral scanner, and owns 110 authorized patents.

Huayuan Regenerative Medicine is the manufacture of implantable bioartificial organs. Huayuan Regenerative Medicine is committed to the research and development, production, and sales of clinical grade stem cells, biological tissue engineering products, and biomanufacturing. Their clinical products include urinary kidney precursor cells, dialysis equipment, and a biosynthetic artificial pancreas.

dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

PackGene Biotech is a United States-based contract research organization and contract development and manufacturing organization that specializes in viral vectors for gene therapies. The company focuses on adeno-associated virus (AAV) vector design, cloning and packaging, as well as production of AAV, lentiviral vectors, mRNA, and plasmid DNA. It serves early-stage drug discovery, preclinical development, and cell and gene therapy trials, delivering scalable, cost-effective production with emphasis on purity, titer and infectivity. PackGene offers customized vector design, construction, and packaging services to support researchers in accelerating gene therapy programs.

YuanHua Zhineng specializes in sophisticated medical and intelligent service robots. The company provides a robot system for orthopedic surgery that can help surgeons with a variety of procedures, including spine, knee/hip replacement, trauma, and knee/hip replacement.

Neuracle is a prominent enterprise in China's neuroscience sector, specializing in neural monitoring and diagnostic technology. Leveraging advanced brain-machine interface technology developed through collaboration with Tsinghua University, Neuracle focuses on innovative research in neuroscience, psychology, and neuroengineering. The company provides comprehensive solutions for the diagnosis, treatment, and rehabilitation of clinical neurological diseases. Its product offerings include digital electroencephalographs and other tools that allow healthcare institutions to monitor patients' brain bioelectricity levels and accurately diagnose neural conditions. Neuracle's research and development efforts have garnered acceptance from experts in both neuroscience and clinical medicine, positioning the company as a leader in its field and a key contributor to national science and technology initiatives.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Babycare is an e-commerce platform providing products for new parents and children. The company specializes in the design, research, and development of mother-baby products. Its products are based on recommendations by a series of research and experiments regarding orthopedic development of babies. One of its products is the infant waist carrier, which is crafted to improve the comfortability of infants and prevent from bowleg posturing which hinders blood circulation. The company is committed to achieving the aspiration of being product designers and baby caretakers. The company was founded in 2014 and is headquartered in Shanghai, China.

NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.

dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

PackGene Biotech is a United States-based contract research organization and contract development and manufacturing organization that specializes in viral vectors for gene therapies. The company focuses on adeno-associated virus (AAV) vector design, cloning and packaging, as well as production of AAV, lentiviral vectors, mRNA, and plasmid DNA. It serves early-stage drug discovery, preclinical development, and cell and gene therapy trials, delivering scalable, cost-effective production with emphasis on purity, titer and infectivity. PackGene offers customized vector design, construction, and packaging services to support researchers in accelerating gene therapy programs.

AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.

Buymed operates a digital pharmaceuticals distribution platform in Vietnam, known as Thuocsi.vn. Founded in 2018 and based in Ho Chi Minh City, the platform supplies a wide range of healthcare products, including medicines, cosmetics, medical devices, and supplements. It serves over 1,000 pharmacies and clinics across the country, offering detailed product information such as pricing and active ingredients. Additionally, Thuocsi.vn features a communication network that provides important updates, including product recalls. The company is recognized as a successful startup in the medical technology sector, attracting young talent eager to integrate advanced technology into healthcare solutions.

SiBionics is a medtech company headquartered in Shenzhen, China, focused on the research, development, and commercialization of active implantable medical devices and medical artificial intelligence. The company specializes in innovative solutions for medical imaging and neuromodulation, striving to create cost-effective products that enhance long-term health monitoring and disease management. SiBionics is developing various advanced technologies, including implanted retinal electrical stimulators, continuous glucose monitoring systems, and screening tools for gastric cancer and chronic diseases. Through the integration of visual coding, artificial intelligence, and medical big data, SiBionics aims to address critical health issues such as retinitis pigmentosa, diabetes, cardiovascular and cerebrovascular diseases, and gastrointestinal tumors, ultimately improving diagnostic and treatment options for these conditions.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Eko.ai Pte. Ltd. is a Singapore-based company that specializes in developing artificial intelligence software for the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound technology to identify cardiovascular risks more effectively. Eko.ai collaborates with clinician scientists, sonographers, and deep learning experts to create automated tools that enhance the capabilities of research teams in the field of cardiac imaging. Its software provides fully classified, machine learning-ready research databases, along with a suite of models, segmentation tools, and validation cohorts. By equipping hospital systems with these productivity tools, Eko.ai aims to improve health outcomes for patient populations while advancing the fight against heart disease.

Fussen Technology, established in 2012 and headquartered in Shenzhen, China, specializes in the development of digital dental imaging equipment. The company focuses on creating comprehensive solutions for the dental healthcare sector, including Cone Beam Computed Tomography (CBCT), Intraoral Scanners (IOS), Imaging Plate Scanners, and a SaaS-based clinic management system. Additionally, Fussen Technology has developed a digital intelligence platform, Dental X-Dental, to streamline dental healthcare services.

Babycare is an e-commerce platform providing products for new parents and children. The company specializes in the design, research, and development of mother-baby products. Its products are based on recommendations by a series of research and experiments regarding orthopedic development of babies. One of its products is the infant waist carrier, which is crafted to improve the comfortability of infants and prevent from bowleg posturing which hinders blood circulation. The company is committed to achieving the aspiration of being product designers and baby caretakers. The company was founded in 2014 and is headquartered in Shanghai, China.

Guangzhou Asensing Electronics Co., Ltd. specializes in the development of inertial navigation and optoelectronic technology solutions. Founded in 2014 and based in Guangzhou, China, the company offers a range of products including vertical gyros, inertial measurement units, attitude heading reference systems, and GPS/INS integrated navigation systems. These products are utilized across various sectors such as aerospace, marine, and industrial applications, serving customers in the fields of aircraft, ships, robots, and somatosensory terminals. In addition to standard offerings, Asensing provides customized solutions, particularly in the areas of UAV platforms and night vision technology. The company's advanced inertial and optoelectronic products enhance dynamic attitude measurement, motion control, and positioning algorithms, contributing to safer and more precise navigation systems.

Medtrum Technologies Inc., established in 2008, specializes in developing and delivering medical devices for diabetes management. Its product portfolio includes the A6 TouchCare System, a tubing-free, semi-closed loop insulin management system that integrates an insulin patch pump and continuous glucose monitoring (CGM) with predictive low glucose suspend features. The S6 EasySense is a waterproof, disposable CGM system providing real-time glucose readings for a week. The P6 EasyPatch is a disposable insulin pump offering adjustable basal rates and bolus on demand. Medtrum's cloud-based healthcare system, comprising the EasyTouch mobile app and EasyView web portal, consolidates patient data for self-management, family support, and healthcare provider access. With headquarters in Shanghai, China, Medtrum also operates in Düsseldorf, Germany; Hong Kong; and Watford, UK.

Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

GRAIL focuses on developing technologies for early cancer detection. Founded in 2016, the company specializes in a pan-cancer screening test that measures circulating nucleic acids in blood using high-intensity sequencing.

NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

Forerunner Medical (Shanghai) Co., Ltd., established in 2009, specializes in the development and manufacturing of innovative medical devices aimed at minimally invasive treatments. The company focuses on creating low-temperature plasma radio-frequency generators and electrodes specifically designed for sports medicine and tumor treatment. By leveraging extensive domestic clinical data and advanced technology, Forerunner Medical aims to meet both domestic and global healthcare needs. The organization emphasizes the quality and safety of its products, ensuring high performance, aesthetic appeal, and user convenience. Its commitment to excellence is reflected in its state-of-the-art production equipment and professional expertise, which contribute to its competitive advantage in the medical device industry.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

Health 724 is a health service provider based on users, health managers, and health products. They offer direct supply of health products to users who are concerned about their own and their families' health, as well as customized health solutions.

Forerunner Medical (Shanghai) Co., Ltd., established in 2009, specializes in the development and manufacturing of innovative medical devices aimed at minimally invasive treatments. The company focuses on creating low-temperature plasma radio-frequency generators and electrodes specifically designed for sports medicine and tumor treatment. By leveraging extensive domestic clinical data and advanced technology, Forerunner Medical aims to meet both domestic and global healthcare needs. The organization emphasizes the quality and safety of its products, ensuring high performance, aesthetic appeal, and user convenience. Its commitment to excellence is reflected in its state-of-the-art production equipment and professional expertise, which contribute to its competitive advantage in the medical device industry.

SyMap Medical is focused on the development and manufacturing of innovative medical devices aimed at treating hypertension and related diseases, including heart failure, arrhythmia, and severe asthma. The company specializes in a proprietary catheter-based renal mapping and ablation system that utilizes radiofrequency (RF) ablation technology. This system is designed for renal denervation therapy, which involves mapping and selectively ablating renal nerves to effectively manage hypertension. Through its advanced technology platform, SyMap Medical aims to address significant health challenges associated with major cardiovascular and respiratory conditions.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

EndoChoice is a medical device company specializing in the development and commercialization of technologies for gastrointestinal (GI) care. Founded in 2008 and headquartered in Alpharetta, Georgia, the company offers a range of products that include single-use devices, diagnostics, infection control products, and endoscopic imaging systems tailored for GI specialists. One of its notable innovations is the Full Spectrum Endoscopy™ System, which features colonoscopes and gastroscopes equipped with multiple imagers, allowing for a wider field of view compared to traditional endoscopes. This technology has demonstrated its efficacy by detecting significantly more polyps during colonoscopy procedures. EndoChoice serves over 2,000 customers in the United States and collaborates with 34 distribution partners globally. The company was recognized by Inc. Magazine as one of the fastest-growing companies in the U.S. for four consecutive years prior to its acquisition by Boston Scientific in 2016.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

B-Lite is provides lightweight breast implants. B-Lite implants reduce gravitational stress on the breast soft-tissue, as well as retain shape and form in the long term.

Whale Imaging Inc., established in 1998, is a Massachusetts-based manufacturer of medical devices specializing in surgical imaging systems and ultrasound equipment. The company's product portfolio includes G-Arm Products like the G-Arm B6 Duo and G-Arm GXi 2, as well as portable ultrasound systems such as the Lambda P9 and Sigma P5. In addition to manufacturing, Whale Imaging offers training services, preventative maintenance, and customer support for its products. The company's headquarters are in Waltham, Massachusetts, with research and development facilities located in Boston.

MENET is a platform for skilled information services that combines market research for hospitals, retail stores, business channels, and online medical and health information services. Their primary service offerings include online information data retrieval via the Internet, including industry tool libraries, global research and development libraries, market pattern libraries, and medical device libraries, as well as offline interactive client - centric offerings like thorough research, market research, terminal monitoring, and strategy consulting.

Whale is a manufacturer of imaging devices, including multi-planar surgical imaging and portable diagnostic ultrasound products. It develops portable ultrasound systems and surgical imaging equipment, employing proprietary technologies and advanced manufacturing methods to produce safe devices that enable surgeons to perform procedures with speed and ease.

EndoChoice is a medical device company specializing in the development and commercialization of technologies for gastrointestinal (GI) care. Founded in 2008 and headquartered in Alpharetta, Georgia, the company offers a range of products that include single-use devices, diagnostics, infection control products, and endoscopic imaging systems tailored for GI specialists. One of its notable innovations is the Full Spectrum Endoscopy™ System, which features colonoscopes and gastroscopes equipped with multiple imagers, allowing for a wider field of view compared to traditional endoscopes. This technology has demonstrated its efficacy by detecting significantly more polyps during colonoscopy procedures. EndoChoice serves over 2,000 customers in the United States and collaborates with 34 distribution partners globally. The company was recognized by Inc. Magazine as one of the fastest-growing companies in the U.S. for four consecutive years prior to its acquisition by Boston Scientific in 2016.

Koncen BioScience was founded by a group of Chinese who returned to the country after completing their educations overseas. This high-technology biomedical enterprise offers integrated research and development, along with manufacturing and marketing services, all focused on blood purification technologies and products.

EndoSpan Ltd., established in 2008 and headquartered in Herzliya, Israel, specializes in the design and development of innovative stent graft systems under the brand name NEXUS. The company focuses on minimally invasive endovascular repair solutions for aortic arch diseases, including aneurysms and dissections. Its portfolio includes the Endo-Vascular Aortic Aneurysm Repair (EVAR) system, which is tailored for both unilateral and percutaneous approaches. By offering differentiated aortic endografts, EndoSpan aims to address the specific needs of patients with aortic lesions, providing effective treatment options in an underserved clinical area. The company is currently in the pre-clinical stage of development and is backed by venture capital.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

Hinacom Software and Technology, Ltd. is a Beijing-based healthcare IT company that specializes in medical imaging and information management solutions. Established in 2008, the company offers its flagship product, miPlatform, an integrated suite designed for the medical imaging industry. This suite encompasses various components, including Enterprise PACS/RIS for optimized workflow management, Regional PACS for collaborative imaging services across hospitals, and TeleMed/TeleRad systems for image transmission and conferencing via web platforms. Additionally, miPlatform features web-based 3D processing and mobile imaging systems. Hinacom’s solutions are utilized by hospitals and regional teleradiology projects in China, as well as by radiologists and clinicians across the United States, Europe, and Southeast Asia.